Literature DB >> 19683687

Value of p16(INK4a) as a marker of progression/regression in cervical intraepithelial neoplasia grade 1.

Marta del Pino1, Sònia Garcia, Victòria Fusté, Immaculada Alonso, Pere Fusté, Aureli Torné, Jaume Ordi.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the usefulness of p16(INK4a) staining to classify cervical intraepithelial neoplasia grade 1 according to its progression/regression risk. STUDY
DESIGN: Patients with a histologic diagnosis of cervical intraepithelial neoplasia grade 1 were prospectively recruited (n = 138). Simultaneous detection of high-risk human papillomaviruses and p16(INK4a) evaluation were performed. Follow-up was conducted every 6 months by cytology and colposcopy and annually by high-risk human papillomavirus testing, for at least 12 months (mean, 29.0). Progression was defined as a histologic diagnosis of cervical intraepithelial neoplasia grades 2-3, regression as a negative cytology and high-risk human papillomaviruses, and persistence as a cytologic result of low-grade squamous intraepithelial lesions and/or a positive test for high-risk human papillomaviruses.
RESULTS: Progression was observed in 14 women (10.1%), 66 (47.6%) regressed, and 58 (42.0%) had a persistent disease. p16(INK4a) was positive in 77 (55.8%) initial biopsy specimens. Progression to cervical intraepithelial neoplasia grades 2-3 was identified in 14 of 77 (18.2%) women with positive and none of 61 (0.00%) women with negative p16(INK4a) immunostaining (P < .001).
CONCLUSION: p16(INK4a) negative cervical intraepithelial neoplasia grade 1 lesions rarely progress and may benefit from a less intensive follow-up.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683687     DOI: 10.1016/j.ajog.2009.05.046

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

1.  Usefulness of p16INK4a staining for managing histological high-grade squamous intraepithelial cervical lesions.

Authors:  Ester Miralpeix; Jordi Genovés; Josep Maria Solé-Sedeño; Gemma Mancebo; Belen Lloveras; Beatriz Bellosillo; Francesc Alameda; Ramon Carreras
Journal:  Mod Pathol       Date:  2016-10-14       Impact factor: 7.842

2.  mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer.

Authors:  Marta Del Pino; Cecilia Svanholm-Barrie; Aureli Torné; Lorena Marimon; Jina Gaber; Amaia Sagasta; David H Persing; Jaume Ordi
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

3.  Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.

Authors:  Alan G Waxman; David Chelmow; Teresa M Darragh; Herschel Lawson; Anna-Barbara Moscicki
Journal:  Obstet Gynecol       Date:  2012-12       Impact factor: 7.661

4.  Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue.

Authors:  Enoc M Cortés-Malagón; José Bonilla-Delgado; José Díaz-Chávez; Alfredo Hidalgo-Miranda; Sandra Romero-Cordoba; Aykut Uren; Haydar Celik; Matthew McCormick; José A Munguía-Moreno; Eloisa Ibarra-Sierra; Jaime Escobar-Herrera; Paul F Lambert; Daniel Mendoza-Villanueva; Rosa M Bermudez-Cruz; Patricio Gariglio
Journal:  Virology       Date:  2013-09-27       Impact factor: 3.616

5.  TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions.

Authors:  Anna Manawapat-Klopfer; Louise T Thomsen; Peter Martus; Christian Munk; Rainer Russ; Hans Gmuender; Kirsten Frederiksen; Juliane Haedicke-Jarboui; Frank Stubenrauch; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2016-07-01       Impact factor: 6.166

6.  Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions.

Authors:  Yuxin Liu; Morgan Blakely; Keith Sigel; Tin Htwe Thin; Pei Hui; Michael Donovan; Michael M Gaisa
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177

7.  p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix.

Authors:  Amaia Sagasta; Paola Castillo; Adela Saco; Aureli Torné; Roser Esteve; Lorena Marimon; Jaume Ordi; Marta Del Pino
Journal:  Mod Pathol       Date:  2015-11-06       Impact factor: 7.842

Review 8.  p16ink4 and cytokeratin 7 immunostaining in predicting HSIL outcome for low-grade squamous intraepithelial lesions: a case series, literature review and commentary.

Authors:  Eric C Huang; Mary M Tomic; Suchanan Hanamornroongruang; Emily E Meserve; Michael Herfs; Christopher P Crum
Journal:  Mod Pathol       Date:  2016-08-12       Impact factor: 7.842

9.  Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.

Authors:  Romy van Baars; Heather Griffin; Zhonglin Wu; Yasmina Jay Soneji; Miekel van de Sandt; Rupali Arora; Jacolien van der Marel; Bram Ter Harmsel; Robert Jach; Krzysztof Okon; Hubert Huras; David Jenkins; Wim Quint; John Doorbar
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

10.  Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions.

Authors:  Fatemeh Sari Aslani; Akbar Safaei; Masoumeh Pourjabali; Mozhdeh Momtahan
Journal:  Iran J Med Sci       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.